FDA
approval
· 2017-01-04
FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
Summary
FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) from Allergan, Inc., authorizing changes to the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VIIBRYD (VILAZODONE HYDROCHLORIDE)